Xingxing Zang

13PUBLICATIONS
59CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 03, 2025
Acquired resistance in cancer: towards targeted therapeutic strategies.

Alice Soragni, Erik S Knudsen, Thomas N O'Connor

|Aug 29, 2024
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints.

Huijie Liu, Ayse Ece Cali Daylan, Jihua Yang

|Aug 10, 2024
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma.

Natalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo

|May 08, 2024
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors.

Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng

|Feb 05, 2024
A Galectin-9-Driven CD11chigh Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia.

Yanhong Li, Yifei Sang, Yunjian Chang

|Jan 03, 2024
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.

Hao Wang, R Alejandro Sica, Gurbakhash Kaur

Pageof 3

Frequent Collaborators

7 joint publications

Deyou Zheng

6 joint publications

Phillip M Galbo

3 joint publications

Yao Wei

2 joint publications

Devin T Corrigan